检索

标题
作者
The clinician's view on the advantages and contradictions of the new nomenclature of steatotic liver disease: A review
Pavlov C., Teplyuk D., Lazebnik L., Ametov A., Pashkova E., Sorokoletov S., Uspenskiy Y., Turkina S., Ponomarenko E., Maslakov A.
Non-alcoholic fatty liver disease: aspects of management of a comorbid patient. A review
Demidova T., Ushanova F.
Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions
Toktogulova N., Sultanalieva R., Tuhvatshin R., Kaliev T.
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
Maevskaya M., Kotovskaya Y., Ivashkin V., Tkacheva O., Troshina E., Shestakova M., Breder V., Geyvandova N., Doshchitsin V., Dudinskaya E., Ershova E., Kodzoeva K., Komshilova K., Korochanskaya N., Mayorov A., Mishina E., Nadinskaya M., Nikitin I., Pogosova N., Tarzimanova A., Shamkhalova M.
Efficacy of human placenta hydrolyzate in the treatment of patients with metabolic associated fatty liver disease at the stage of fibrosis (pilot study)
Vinnitskaya E., Sandler Y., Saliev K., Ivanov A., Sbikina E., Khaymenova T., Bordin D.
The study of abdominal and parietal enteric microbiota in patients with non-alcoholic fatty liver disease
Vakhrushev Y., Lukashevich A., Lyapina M.
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy
Petunina N., Telnova M., Goncharova E., Martirosian N., Kuzina I.
Subclinical markers of liver damage in patients with arterial hypertension and obesity
Sadulaeva I., Yushchuk E., Khalikova L., Krikunova O., Trofimenko O., Medvedeva E.
Evaluation of cardiovascular remodeling and epicardial fat thickness in patients with chronic heart failure and metabolic syndrome
Drapkina O., Zyatenkova E.
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
Assessment of body mass index in patients with chronic hepatitis C who received an effective antiviral therapy
Dudina K., Belyy P., Maev I., Klimova E., Shutko S., Znoyko O., Yuschuk N.
Use of a controlled attenuation parameter for the diagnosis of non-alcoholic fatty liver disease
Goncharov A., Sasunova A., Pilipenko V., Isakov V.
Modification of dietary patterns in patients with non-alcoholic steatohepatitis
Sasunova A., Goncharov A., Morozov S., Isakov V.
Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features
Kalmykova Z., Kononenko I., Mayorov A.
Possibilities for the use of ursodeoxycholic acid in the treatment of patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
Rasskazova M., Vorobyev S., Butova H.
Diabetes mellitus and chronic liver diseases. Part 1: general mechanisms of etiology and pathogenesis
Kalmykova Z., Kononenko I., Mayorov A.
Mixed steatohepatitis: more questions than answers (part 2)
Raikhelson K., Kondrashina E., Pazenko E.
Obesity as a risk factor for diseases of the digestive system
Andreev D., Kucheryavyy Y.
Mixed steatohepatitis: more questions than answers (Part 1)
Raikhelson K., Kondrashina E., Pazenko E.
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics
Anisonyan A., Sandler Y., Khaimenova T., Keyan V., Saliev K., Sbikina E., Vinnitskaya E.
Clinical features of the comorbid course of non-alcoholic fatty liver disease and gallstone disease
Cherkashchenko N., Livzan M., Krolevets T.
Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies
Nosov A., Zenina M., Gorbushina O., Baidina A., Vlasova E., Alekseev V.
Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease
Cherkashchenko N., Livzan M., Krolevets T.
Nonalcoholic fatty liver disease: What do we know and what will we have to learn?
Volkova N., Porksheyan M.
Non - alcoholic fatty liver disease and enteral insufficiency: comorbidity of their development
Vakhrushev Y., Suchkova E., Lukashevich A.
Involvement of the hepatobiliary system and pancreas in obesity
Akhmedov V., Gaus O.
Peculiarities of heart risk in patients with non - alcoholic fatial liver disease
Mosina L., Stolyarova V., Esina M., Titojkina Y., Korobkov D.
Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome
Pavlov A., Ivolgin A., Katenko S., Eremin M., Molodova A., Levchenko O., Karakozov A.
Evaluation of the efficiency of hepatoprotective monotherapy using succinic acid and methionine for nonalcoholic fatty liver disease at the stage of steatohepatitis
Semiserin V., Karakozov A., Malkuta M., Zolotareva L., Levchenko O., Kalyagin I., Eremin M.
Intrahepatic cholestasis in nonalcoholic fatty liver disease
Shipovskaya A., Dudanova O.
The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease
Shipovskaya A., Dudanova O., Kurbatova I.
Clinical and metabolic features of nonalcoholic fatty liver disease in men and women
Krivosheev A., Kuimov A., Bogoryanova P., Kondratova M., Kupriyanova L., Popov K., Tuguleva T.
The importance of the bacterial overgrowth syndrome in the development of disorders metabolic functions of the liver in non-alcoholic fatty liver disease
Vakhrushev Y., Lukashevich A.
Evaluation of the effectiveness of differentiated therapy of non-alcoholic fatty liver disease
Vakhrushev Y., Suchkova E., Lukashevich A.
Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease
Akhmedov V., Gaus O.
The informative value of non-invasive liver fibrosis markers in patients with nonalcoholic fatty liver disease
Livzan M., Akhmedov V., Krolevets T., Gaus O., Cherkaschenko N.
Current approaches to diagnosing and treating nonalcoholic fatty liver disease
Drapkina O., Deeva T., Volkova N., Ivashkin V.
Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy
Maevskaya M., Ivashkin V., Ivashkin K., Lunkov V., Liusina E., Zozula V., Leshchenko V.
Nonalcoholic steatohepatitis and biliary sludge in people with metabolic syndrome
Radchenko V., Seliverstov P., Ledentsova S., Manyakov A.
Adiponectin and parameters of glucose and lipid metabolism at different clinical and morphological stages of non-alcoholic fatty liver disease in patients with abdominal obesity
Komshilova K., Troshina E., Ershova E., Mazurina N., Platonova N.
1 - 40 的 40 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##